|
|
Office Locations:
|
501 5th Ave, Suite 1404
New York, NY 10017
| |
|
|
|
|
|
|
Life Sciences & Healthcare
|
|
|
|
Adjuvant Capital is a life sciences investment firm focused on global health. The firm makes $10 million to $25 million investments in companies targeting opportunities in high burden and neglected disease. Adjuvant was incubated at the Global Health Investment Fund (GHIF) and now stands as an independent investment platform designed to scale the most promising investment strategies developed within the original portfolio.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
